Apoptotic Mitochondrial Poration by a Growing List of Pore-forming BCL-2 Family Proteins

Overview

Journal Bioessays

Publisher Wiley

Specialties Biology
Cell Biology
Molecular Biology

Date 2023 Jan 18

PMID 36650950

Authors

Tudor Moldoveanu

Affiliations

Soon will be listed here.

Abstract

The pore-forming BCL-2 family proteins are effectors of mitochondrial poration in apoptosis initiation. Two atypical effectors-BOK and truncated BID (tBID)-join the canonical effectors BAK and BAX. Gene knockout revealed developmental phenotypes in the absence the effectors, supporting their roles in vivo. During apoptosis effectors are activated and change shape from dormant monomers to dynamic oligomers that associate with and permeabilize mitochondria. BID is activated by proteolysis, BOK accumulates on inhibition of its degradation by the E3 ligase gp78, while BAK and BAX undergo direct activation by BH3-only initiators, autoactivation, and crossactivation. Except tBID, effector oligomers on the mitochondria appear as arcs and rings in super-resolution microscopy images. The BH3-in-groove dimers of BAK and BAX, the tBID monomers, and uncharacterized BOK species are the putative building blocks of apoptotic pores. Effectors interact with lipids and bilayers but the mechanism of membrane poration remains elusive. I discuss effector-mediated mitochondrial poration.

Citing Articles

Cytotoxic Activity of L. Methanolic Extract on Human Colorectal Cancer Cells, Caco-2, through p53-Mediated Apoptosis.

Gallegos-Saucedo R, Barrios-Garcia T, Valdez-Morales E, Cabanas-Garcia E, Barajas-Espinosa A, Gomez-Aguirre Y Molecules. 2024; 29(16).

PMID: 39202999 PMC: 11357562. DOI: 10.3390/molecules29163920.

Promotion of osteochondral repair through immune microenvironment regulation and activation of endogenous chondrogenesis via the release of apoptotic vesicles from donor MSCs.

Tian G, Yin H, Zheng J, Yu R, Ding Z, Yan Z Bioact Mater. 2024; 41:455-470.

PMID: 39188379 PMC: 11347043. DOI: 10.1016/j.bioactmat.2024.07.034.

Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma.

Wang J, Ma C, Tang Z, Sun Z, Qaed E, Chi X Cancer Cell Int. 2024; 24(1):17.

PMID: 38185661 PMC: 10771654. DOI: 10.1186/s12935-023-03119-x.

AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens.

Milnerowicz S, Maszewska J, Skowera P, Stelmach M, Lejman M Int J Mol Sci. 2023; 24(21).

PMID: 37958832 PMC: 10647248. DOI: 10.3390/ijms242115849.

Bok: real killer or bystander with non-apoptotic roles?.

Bonzerato C, Wojcikiewicz R Front Cell Dev Biol. 2023; 11:1161910.

PMID: 37123400 PMC: 10130511. DOI: 10.3389/fcell.2023.1161910.

References

Uren R, Iyer S, Kluck R . Pore formation by dimeric Bak and Bax: an unusual pore?. Philos Trans R Soc Lond B Biol Sci. 2017; 372(1726). PMC: 5483520. DOI: 10.1098/rstb.2016.0218. View

Salisbury-Ruf C, Bertram C, Vergeade A, Lark D, Shi Q, Heberling M . Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife. 2018; 7. PMC: 6234033. DOI: 10.7554/eLife.40907. View

Czabotar P, Westphal D, Dewson G, Ma S, Hockings C, Fairlie W . Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell. 2013; 152(3):519-31. DOI: 10.1016/j.cell.2012.12.031. View

Sekar G, Singh G, Qin X, Guibao C, Schwam B, Inde Z . Small molecule SJ572946 activates BAK to initiate apoptosis. iScience. 2022; 25(10):105064. PMC: 9485059. DOI: 10.1016/j.isci.2022.105064. View

Ren D, Tu H, Kim H, Wang G, Bean G, Takeuchi O . BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science. 2010; 330(6009):1390-3. PMC: 3163443. DOI: 10.1126/science.1190217. View

Billen L, Shamas-Din A, Andrews D . Bid: a Bax-like BH3 protein. Oncogene. 2009; 27 Suppl 1:S93-104. DOI: 10.1038/onc.2009.47. View

Lauterwasser J, Todt F, Zerbes R, Nguyen T, Craigen W, Lazarou M . The porin VDAC2 is the mitochondrial platform for Bax retrotranslocation. Sci Rep. 2016; 6:32994. PMC: 5020405. DOI: 10.1038/srep32994. View

Riley J, Quarato G, Cloix C, Lopez J, OPrey J, Pearson M . Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. EMBO J. 2018; 37(17). PMC: 6120664. DOI: 10.15252/embj.201899238. View

Leshchiner E, Braun C, Bird G, Walensky L . Direct activation of full-length proapoptotic BAK. Proc Natl Acad Sci U S A. 2013; 110(11):E986-95. PMC: 3600461. DOI: 10.1073/pnas.1214313110. View

10.

Grosse L, Wurm C, Bruser C, Neumann D, Jans D, Jakobs S . Bax assembles into large ring-like structures remodeling the mitochondrial outer membrane in apoptosis. EMBO J. 2016; 35(4):402-13. PMC: 4755111. DOI: 10.15252/embj.201592789. View

11.

Chen H, Kanai M, Inoue-Yamauchi A, Tu H, Huang Y, Ren D . An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nat Cell Biol. 2015; 17(10):1270-81. PMC: 4589531. DOI: 10.1038/ncb3236. View

12.

Chipuk J, McStay G, Bharti A, Kuwana T, Clarke C, Siskind L . Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell. 2012; 148(5):988-1000. PMC: 3506012. DOI: 10.1016/j.cell.2012.01.038. View

13.

McArthur K, Whitehead L, Heddleston J, Li L, Padman B, Oorschot V . BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science. 2018; 359(6378). DOI: 10.1126/science.aao6047. View

14.

Wei M, Zong W, Cheng E, LINDSTEN T, Panoutsakopoulou V, Ross A . Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292(5517):727-30. PMC: 3049805. DOI: 10.1126/science.1059108. View

15.

Letai A, Bassik M, Walensky L, Sorcinelli M, Weiler S, Korsmeyer S . Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2002; 2(3):183-92. DOI: 10.1016/s1535-6108(02)00127-7. View

16.

Schulman J, Szczesniak L, Bunker E, Nelson H, Roe M, Wagner 2nd L . Bok regulates mitochondrial fusion and morphology. Cell Death Differ. 2019; 26(12):2682-2694. PMC: 7224202. DOI: 10.1038/s41418-019-0327-4. View

17.

Marchi S, Guilbaud E, Tait S, Yamazaki T, Galluzzi L . Mitochondrial control of inflammation. Nat Rev Immunol. 2022; 23(3):159-173. PMC: 9310369. DOI: 10.1038/s41577-022-00760-x. View

18.

Chou J, Li H, Salvesen G, Yuan J, Wagner G . Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell. 1999; 96(5):615-24. DOI: 10.1016/s0092-8674(00)80572-3. View

19.

Yuan Z, Dewson G, Czabotar P, Birkinshaw R . VDAC2 and the BCL-2 family of proteins. Biochem Soc Trans. 2021; 49(6):2787-2795. PMC: 8786305. DOI: 10.1042/BST20210753. View

20.

Czabotar P, Lessene G, Strasser A, Adams J . Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2013; 15(1):49-63. DOI: 10.1038/nrm3722. View